FDA Posts Annual Forecast for Planned Monograph Activities - Drug Information Update

If your email program has trouble displaying this email, view it as a web page. FDA Posts Annual Forecast for Planned Monograph Activities Today, the US Food and Drug Administration posted the first Annual Forecast for Planned Monograph Activities. The Annual Forecast is a nonbinding list, issued each year, of planned monograph activities that FDA intends to address over the upcoming three years. Topics of planned monograph activities on this year's Annual Forecast include: Risks associated with codeine-containing cough medicine Pediatric acetaminophen dosing Risks associated with propylhexedrine abuse and misuse Nonsteroidal anti-inflammatory drugs and oligohydramnios Oral healthcare in infants and children Serious skin reactions associated with acetaminophen Anticaries test methods The Annual Forecast is a list of planned activities and is not a commitment from FDA that these activities will be addressed over the next three years. For more information about OTC Monograph Reform, visit FDA's webpage Over-the-Counter (OTC) Drug Review | OTC Monograph Reform in the CARES Act. This is an automated message delivery system. Replying to this message will not reach DDI staff. If you have comments or questions, please contact us at: 1-888-INFO- FDA (1-888-463-6332) or 301-796-3400 from 8:00 am - 4:30 pm ET Monday - Friday. You can also email us at: druginfo@fda.hhs.gov. Stay Connected with U.S. Food and Drug Administration:         SUBSCRIBER SERVICES: Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA